These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 22949131

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P, Boorman GC, Donald AE, Davies HD.
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [Abstract] [Full Text] [Related]

  • 23. Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
    Draelos ZD, Rodriguez DA, Kempers SE, Bruce S, Peredo MI, Downie J, Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A.
    J Drugs Dermatol; 2017 Jun 01; 16(6):591-598. PubMed ID: 28686777
    [Abstract] [Full Text] [Related]

  • 24. Severe methemoglobinemia due to topical dapsone misuse in a teenage girl.
    Yale S, Stefanko N, McCarthy P, McFadden V, McCarthy J.
    Pediatr Dermatol; 2020 Mar 01; 37(2):377-378. PubMed ID: 31876314
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E, Harper J, Baldwin H, Kircik L, Bai Z, Alvandi N.
    J Drugs Dermatol; 2018 Nov 01; 17(11):1192-1198. PubMed ID: 30500141
    [Abstract] [Full Text] [Related]

  • 27. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E, Harper J, Baldwin H, Kircik L, Bai Z, Alvandi N.
    J Drugs Dermatol; 2018 Nov 01; 17(11):1192-1198. PubMed ID: 30500140
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J, Wojas-Pelc A, Walczewska M, Lipko-Godlewska S, Jachowicz R, Maciejewska A, Białecka A, Kasprowicz A.
    Eur J Dermatol; 2008 Nov 01; 18(4):433-9. PubMed ID: 18573718
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Taurine bromamine: a new therapeutic option in inflammatory skin diseases.
    Marcinkiewicz J.
    Pol Arch Med Wewn; 2009 Oct 01; 119(10):673-6. PubMed ID: 19847145
    [Abstract] [Full Text] [Related]

  • 34. What's new in acne and rosacea?
    Keri J.
    Semin Cutan Med Surg; 2016 Jun 01; 35(2):103-6. PubMed ID: 27416316
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Acne inversa: a dapsone-sensitive dermatosis].
    Hofer T, Itin PH.
    Hautarzt; 2001 Oct 01; 52(10 Pt 2):989-92. PubMed ID: 11715401
    [Abstract] [Full Text] [Related]

  • 37. An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color.
    El-Kashlan N, Cices A, Kaufman B, Da Rosa JC, Sanabria-Gonzalez I, Khattri S, Alexis A.
    J Drugs Dermatol; 2024 Jun 01; 23(6):410-417. PubMed ID: 38834229
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E, Dhawan S, Torok H, Kircik L.
    Dermatol Online J; 2007 Jul 13; 13(3):1. PubMed ID: 18328195
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.